Miwa Morikawa

734 total citations
39 papers, 465 citations indexed

About

Miwa Morikawa is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Epidemiology. According to data from OpenAlex, Miwa Morikawa has authored 39 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 9 papers in Infectious Diseases and 9 papers in Epidemiology. Recurrent topics in Miwa Morikawa's work include Lung Cancer Diagnosis and Treatment (7 papers), Medical Imaging and Pathology Studies (7 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Miwa Morikawa is often cited by papers focused on Lung Cancer Diagnosis and Treatment (7 papers), Medical Imaging and Pathology Studies (7 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Miwa Morikawa collaborates with scholars based in Japan, United States and Germany. Miwa Morikawa's co-authors include Yukihiro Umeda, Shingo Ameshima, Hidehiko Okazawa, Yoshiki Demura, Takeshi Ishizaki, Tatsuro Tsuchida, Yasuhisa Fujibayashi, Masaki Anzai, Tamotsu Ishizuka and Maiko Kadowaki and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and Annals of Oncology.

In The Last Decade

Miwa Morikawa

34 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miwa Morikawa Japan 12 226 127 101 87 80 39 465
Fabio Maggi Italy 11 184 0.8× 167 1.3× 79 0.8× 43 0.5× 53 0.7× 21 400
Javzandulam Natsag Japan 12 230 1.0× 88 0.7× 19 0.2× 49 0.6× 66 0.8× 16 438
Makoto Kurai Japan 11 285 1.3× 41 0.3× 81 0.8× 48 0.6× 104 1.3× 41 469
Travis Wd United States 6 324 1.4× 72 0.6× 44 0.4× 108 1.2× 89 1.1× 9 511
Yongmei Liu China 14 336 1.5× 85 0.7× 39 0.4× 174 2.0× 43 0.5× 31 684
Todd Williams United States 11 278 1.2× 68 0.5× 58 0.6× 174 2.0× 36 0.5× 21 541
Rebecca M. Lindell United States 11 555 2.5× 299 2.4× 81 0.8× 71 0.8× 168 2.1× 15 832
K. Dardoufas Greece 13 366 1.6× 143 1.1× 43 0.4× 148 1.7× 46 0.6× 25 581
Hoang Q. Pham United States 5 162 0.7× 72 0.6× 60 0.6× 94 1.1× 20 0.3× 8 474
Sakashi Fujimori Japan 12 508 2.2× 88 0.7× 31 0.3× 60 0.7× 46 0.6× 40 653

Countries citing papers authored by Miwa Morikawa

Since Specialization
Citations

This map shows the geographic impact of Miwa Morikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miwa Morikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miwa Morikawa more than expected).

Fields of papers citing papers by Miwa Morikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miwa Morikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miwa Morikawa. The network helps show where Miwa Morikawa may publish in the future.

Co-authorship network of co-authors of Miwa Morikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Miwa Morikawa. A scholar is included among the top collaborators of Miwa Morikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miwa Morikawa. Miwa Morikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takahashi, Hidenori, Toru Awaya, Ryutaro Hirose, et al.. (2025). Eosinophilic Myocarditis Treated with IL-5 Blockade: An Integrated Case Report and Literature Review. Journal of Clinical Medicine. 14(19). 6829–6829.
2.
3.
Kotaki, Ryutaro, Saya Moriyama, Taishi Onodera, et al.. (2024). Repeated Omicron exposures redirect SARS-CoV-2–specific memory B cell evolution toward the latest variants. Science Translational Medicine. 16(761). eadp9927–eadp9927. 10 indexed citations
4.
Takahashi, Hidenori, Miwa Morikawa, Ryutaro Hirose, et al.. (2024). Diagnostic utility of pharyngeal follicular structures in COVID-19: A large-scale cross-sectional study. International Journal of Infectious Diseases. 149. 107244–107244. 1 indexed citations
5.
Shinoda, Masahiro, Naoki Ishii, Saki Yamamoto, et al.. (2024). Comparison of liver fibrosis scores and fatty liver on computed tomography as risk factors for severity of COVID‐19. JGH Open. 8(8). e70004–e70004. 2 indexed citations
6.
Takahashi, Hidenori, Shinichiro Ota, Miwa Morikawa, et al.. (2024). Surveillance of seasonal influenza viruses during the COVID‐19 pandemic in Tokyo, Japan, 2018–2023, a single‐center study. Influenza and Other Respiratory Viruses. 18(1). e13248–e13248. 7 indexed citations
7.
Shinoda, Masahiro, et al.. (2023). A case of reinfection with a different variant of SARS-CoV-2: case report. SHILAP Revista de lepidopterología. 35(1). 13–13.
8.
Ota, Shinichiro, Takashi Matsumoto, Miwa Morikawa, et al.. (2020). A case of COVID-19 pneumonia successfully treated with favipiravir (Avigan) in which serum SARS-CoV-2 RNA detected by LAMP method was clinically useful. Journal of Infection and Chemotherapy. 27(2). 379–383. 2 indexed citations
9.
Umeda, Yukihiro, Miwa Morikawa, Masaki Anzai, et al.. (2020). Predictive value of integrated 18F-FDG PET/MRI in the early response to nivolumab in patients with previously treated non-small cell lung cancer. Journal for ImmunoTherapy of Cancer. 8(1). e000349–e000349. 22 indexed citations
10.
Umeda, Yukihiro, Tetsuya Tsujikawa, Masaki Anzai, et al.. (2019). The vertebral 3′-deoxy-3′-18F-fluorothymidine uptake predicts the hematological toxicity after systemic chemotherapy in patients with lung cancer. European Radiology. 29(7). 3908–3917. 5 indexed citations
11.
Kadowaki, Maiko, Hidenori Yamada, Kōichi Sato, et al.. (2019). Extracellular acidification-induced CXCL8 production through a proton-sensing receptor OGR1 in human airway smooth muscle cells: a response inhibited by dexamethasone. Journal of Inflammation. 16(1). 4–4. 15 indexed citations
12.
Yano, Ryoichi, Shinji Yamashita, Kyohei Watanabe, et al.. (2018). Influence of UGT1A1 polymorphism on etoposide plus platinum-induced neutropenia in Japanese patients with small-cell lung cancer. International Journal of Clinical Oncology. 24(3). 256–261. 5 indexed citations
13.
Sasaki, Masato, Masaki Anzai, Miwa Morikawa, et al.. (2017). P2.02-024 Phase I and II Trial of Intrapleural Paclitaxel Injection for Non-Small-Cell Lung Cancer Patients with Malignant Pleural Effusions. Journal of Thoracic Oncology. 12(1). S861–S862. 1 indexed citations
14.
15.
Ishizaki, Takeshi, Shiro Mizuno, Akio Sakai, et al.. (2015). Blunted Activation of Rho-Kinase in Yak Pulmonary Circulation. BioMed Research International. 2015. 1–5. 14 indexed citations
16.
Umeda, Yukihiro, Yoshiki Demura, Miwa Morikawa, et al.. (2015). Prognostic Value of Dual-Time-Point 18F-FDG PET for Idiopathic Pulmonary Fibrosis. Journal of Nuclear Medicine. 56(12). 1869–1875. 36 indexed citations
17.
Umeda, Yukihiro, Yoshiki Demura, Masaki Anzai, et al.. (2014). 18F-FDG uptake predicts diagnostic yield of transbronchial biopsy in peripheral lung cancer. Lung Cancer. 85(1). 47–52. 8 indexed citations
18.
Umeda, Yukihiro, Yoshiki Demura, Miwa Morikawa, et al.. (2011). Prognostic value of dual‐time‐point 18F‐fluorodeoxyglucose positron emission tomography in patients with pulmonary sarcoidosis. Respirology. 16(4). 713–720. 36 indexed citations
19.
Morikawa, Miwa, Yoshiki Demura, Shiro Mizuno, et al.. (2008). FDG positron emission tomography imaging of drug-induced pneumonitis. Annals of Nuclear Medicine. 22(4). 335–338. 9 indexed citations
20.
Morikawa, Miwa, Yoshiki Demura, Takeshi Ishizaki, et al.. (2008). The Effectiveness of 18F-FDG PET/CT Combined with STIR MRI for Diagnosing Nodal Involvement in the Thorax. Journal of Nuclear Medicine. 50(1). 81–87. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fabio Maggi Breakdown of academic impact, for papers by Javzandulam Natsag Breakdown of academic impact, for papers by Makoto Kurai Breakdown of academic impact, for papers by Travis Wd Breakdown of academic impact, for papers by Yongmei Liu Breakdown of academic impact, for papers by Todd Williams Breakdown of academic impact, for papers by Rebecca M. Lindell Breakdown of academic impact, for papers by K. Dardoufas Breakdown of academic impact, for papers by Hoang Q. Pham Breakdown of academic impact, for papers by Sakashi Fujimori
Rankless by CCL
2026